Search research articles
Contact Us
Filters
Showing results (41-50 of 79) with videos related to
Page
of 8
Sort By:
Journal of Neuro-Oncology
|
January 23, 2014
A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomas
Jeffrey J Raizer, Sean A Grimm, Alfred Rademaker, et al.
Neuro-Oncology
|
April 17, 2007
Survey of treatment recommendations for anaplastic oligodendroglioma
Lauren E Abrey, David N Louis, Nina Paleologos, et al.
Journal of Neuro-Oncology
|
January 28, 2026
A phase 2, open label, clinical trial of pre-surgical and adjuvant treatment of recurrent glioblastoma with tremelimumab and durvalumab alone and in combination
Karan S Dixit, Priya Kumthekar, Rimas V Lukas, et al.
Neuro-Oncology
|
February 8, 2011
A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma
Patrick Y Wen, David Schiff, Timothy F Cloughesy, et al.
Neuro-Oncology
|
February 22, 2008
Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features
Jeffrey J Raizer, Wen-Jen Hwu, Katherine S Panageas, et al.
Cancers
|
June 19, 2024
A Phase II Trial of Bevacizumab in Patients with Recurrent/Progressive Solid Tumor Brain Metastases That Have Progressed Following Whole-Brain Radiation Therapy
Karan Dixit, Lauren Singer, Sean Aaron Grimm, et al.
Neuro-Oncology Practice
|
June 3, 2015
Concordance of patient and caregiver reports in evaluating quality of life in patients with malignant gliomas and an assessment of caregiver burden
Daniel I Jacobs, Priya Kumthekar, Becky V Stell, et al.
Oncoimmunology
|
September 14, 2016
Improving vaccine efficacy against malignant glioma
Erik Ladomersky, Matthew Genet, Lijie Zhai, et al.
Journal of Neuro-Oncology
|
October 24, 2021
A multi-center prospective study of re-irradiation with bevacizumab and temozolomide in patients with bevacizumab refractory recurrent high-grade gliomas
Karan S Dixit, Sean Sachdev, Christina Amidei, et al.
Neuro-Oncology Advances
|
October 13, 2022
A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma
Priya Kumthekar, Sean Aaron Grimm, Roxanne T Aleman, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 79) with videos related to
Sort By:
Page
of 8
Journal of Neuro-Oncology
|
January 23, 2014
A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomas
Jeffrey J Raizer, Sean A Grimm, Alfred Rademaker, et al.
Neuro-Oncology
|
April 17, 2007
Survey of treatment recommendations for anaplastic oligodendroglioma
Lauren E Abrey, David N Louis, Nina Paleologos, et al.
Journal of Neuro-Oncology
|
January 28, 2026
A phase 2, open label, clinical trial of pre-surgical and adjuvant treatment of recurrent glioblastoma with tremelimumab and durvalumab alone and in combination
Karan S Dixit, Priya Kumthekar, Rimas V Lukas, et al.
Neuro-Oncology
|
February 8, 2011
A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma
Patrick Y Wen, David Schiff, Timothy F Cloughesy, et al.
Neuro-Oncology
|
February 22, 2008
Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features
Jeffrey J Raizer, Wen-Jen Hwu, Katherine S Panageas, et al.
Cancers
|
June 19, 2024
A Phase II Trial of Bevacizumab in Patients with Recurrent/Progressive Solid Tumor Brain Metastases That Have Progressed Following Whole-Brain Radiation Therapy
Karan Dixit, Lauren Singer, Sean Aaron Grimm, et al.
Neuro-Oncology Practice
|
June 3, 2015
Concordance of patient and caregiver reports in evaluating quality of life in patients with malignant gliomas and an assessment of caregiver burden
Daniel I Jacobs, Priya Kumthekar, Becky V Stell, et al.
Oncoimmunology
|
September 14, 2016
Improving vaccine efficacy against malignant glioma
Erik Ladomersky, Matthew Genet, Lijie Zhai, et al.
Journal of Neuro-Oncology
|
October 24, 2021
A multi-center prospective study of re-irradiation with bevacizumab and temozolomide in patients with bevacizumab refractory recurrent high-grade gliomas
Karan S Dixit, Sean Sachdev, Christina Amidei, et al.
Neuro-Oncology Advances
|
October 13, 2022
A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma
Priya Kumthekar, Sean Aaron Grimm, Roxanne T Aleman, et al.
Page
of 8